{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:49:55Z","timestamp":1792590595124,"version":"4.5.0"},"reference-count":114,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,10,21]]},"DOI":"10.1167\/iovs.67.12.38","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:30:38Z","timestamp":1792589438000},"page":"38","source":"Crossref","is-referenced-by-count":0,"title":["USP10 Silencing Prevents Scarring and Inflammation in a Modified Rabbit Model of Glaucoma Filtration Surgery"],"prefix":"10.1167","volume":"67","author":[{"given":"Christine","family":"Tilstra-Smith","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nileyma","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"},{"name":"New York VA Health Care, Syracuse VA Medical Center, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Anjum","family":"Shaik","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian G.","family":"Temnycky","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunkumar","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelissa","family":"Reynoso-Garcia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zuber","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi S.","family":"Ganapathy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey M.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States"},{"name":"New York VA Health Care, Syracuse VA Medical Center, Syracuse, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","first-page":"e11686","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"147983","DOI":"10.1016\/j.gene.2023.147983","article-title":"Beyond the optic nerve: genetics, diagnosis, and promising therapies for glaucoma","volume":"894","author":"Kaushik","year":"2024","journal-title":"Gene"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40137-022-00311-2","article-title":"Minimally invasive glaucoma surgery: where we are, and what the future holds","volume":"10","author":"Rifai","year":"2022","journal-title":"Curr Surg Rep"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","article-title":"Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up","volume":"127","author":"Gedde","year":"2020","journal-title":"Ophthalmology"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","article-title":"Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of follow-up","volume":"129","author":"Gedde","year":"2022","journal-title":"Ophthalmology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/IJO.IJO_2013_23","article-title":"Wound modulation in glaucoma surgery: the role of anti-scarring agents","volume":"72","author":"Kavitha","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.exer.2018.02.018","article-title":"Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury","volume":"170","author":"Lassance","year":"2018","journal-title":"Exp Eye Res"},{"key":"bib8","first-page":"43","article-title":"Mechanisms for the resolution of organ fibrosis","volume":"34","author":"Horowitz","year":"2019","journal-title":"Physiology (Bethesda)"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1369\/0022155419852932","article-title":"Renal inflammation and fibrosis: a double-edged sword","volume":"67","author":"Black","year":"2019","journal-title":"J Histochem Cytochem"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"issue":"Suppl 1)","key":"bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12886-015-0134-8","article-title":"Pathobiology of wound healing after glaucoma filtration surgery","volume":"15","author":"Yamanaka","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12886-021-01949-9","article-title":"Comparison of 5-year outcomes between trabeculectomy combined with phacoemulsification and trabeculectomy followed by phacoemulsification: a retrospective cohort study","volume":"21","author":"Arimura","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/issn.0250-3751","article-title":"Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules","volume":"59","author":"Hollo","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jcrs.2006.05.014","article-title":"Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy","volume":"32","author":"Rajan","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"bib15","first-page":"1828","article-title":"Quiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healing","volume":"18","author":"Jester","year":"2012","journal-title":"Mol Vis"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","article-title":"Serious complications of topical mitomycin-C after pterygium surgery","volume":"99","author":"Rubinfeld","year":"1992","journal-title":"Ophthalmology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/bjo.86.3.357","article-title":"Serious corneoscleral complications after pterygium excision with mitomycin C","volume":"86","author":"Safianik","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: the steroids for corneal ulcers trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ajo.2013.09.025","article-title":"The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial","volume":"157","author":"Srinivasan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/ICL.0000000000000584","article-title":"Systematic review on therapeutic strategies to minimize corneal stromal scarring after injury","volume":"45","author":"Kwok","year":"2019","journal-title":"Eye Contact Lens"},{"key":"bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.exer.2014.02.007","article-title":"Wounding the cornea to learn how it heals","volume":"121C","author":"Stepp","year":"2014","journal-title":"Exp Eye Res"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2018.08.009","article-title":"Current and upcoming therapies to modulate skin scarring and fibrosis","volume":"146","author":"Coentro","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/wound.2012.0365","article-title":"Integrin \u00df1: a mechanosignaling sensor essential for connective tissue deposition by fibroblasts","volume":"2","author":"Leask","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","article-title":"The extracellular matrix and transforming growth factor-\u00df1: tale of a strained relationship","volume":"47","author":"Hinz","year":"2015","journal-title":"Matrix Biol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J Cell Biol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","article-title":"Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship","volume":"87","author":"Wipff","year":"2008","journal-title":"Eur J Cell Biol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","article-title":"Targeting of av integrin identifies a core molecular pathway that regulates fibrosis in several organs","volume":"19","author":"Henderson","year":"2013","journal-title":"Nat Med"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/jcmm.12213","article-title":"The roles of aV integrins in lens EMT and posterior capsular opacification","volume":"18","author":"Mamuya","year":"2014","journal-title":"J Cell Mol Med"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1242\/jcs.204628","article-title":"The deubiquitylase USP10 regulates integrin \u00df1 and \u00df5 and fibrotic wound healing","volume":"130","author":"Gillespie","year":"2017","journal-title":"J Cell Sci"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"151347","DOI":"10.1016\/j.ejcb.2023.151347","article-title":"The formin DAAM1 regulates the deubiquitinase activity of USP10 and integrin homeostasis","volume":"102","author":"Phillips","year":"2023","journal-title":"Eur J Cell Biol."},{"key":"bib33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.62.13.15","article-title":"USP10 promotes fibronectin recycling, secretion, and organization","volume":"62","author":"Phillips","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"144","key":"bib34","first-page":"10.3791\/58562","article-title":"Ex vivo corneal organ culture model for wound healing studies","author":"Castro","year":"2019","journal-title":"J Vis Exp"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.omtn.2020.07.032","article-title":"USP10 targeted self-deliverable siRNA to prevent scarring in the cornea","volume":"21","author":"Boumil","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"bib36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ajpath.2025.10.006","article-title":"Silencing USP10 alleviates persistent corneal epithelial defect in mice","volume":"196","author":"Banerjee","year":"2026","journal-title":"Am J Pathol"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1038\/mtna.2015.38","article-title":"Hydrophobically modified siRNAs silence Huntingtin mRNA in primary neurons and mouse brain","volume":"4","author":"Alterman","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/jop.2013.0148","article-title":"Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eye","volume":"29","author":"Byrne","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/nar\/gky037","article-title":"Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo","volume":"46","author":"Hassler","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"gkaf479","DOI":"10.1093\/nar\/gkaf479","article-title":"Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy","volume":"53","author":"Davis","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"e0157404","DOI":"10.1371\/journal.pone.0157404","article-title":"Autophagy and mitochondrial dysfunction in Tenon fibroblasts from exfoliation glaucoma patients","volume":"11","author":"Want","year":"2016","journal-title":"PLoS One"},{"key":"bib43","first-page":"1639","article-title":"Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit","volume":"38","author":"Cordeiro","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0161-6420(93)31640-4","article-title":"Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit","volume":"100","author":"Khaw","year":"1993","journal-title":"Ophthalmology"},{"key":"bib45","first-page":"1945","article-title":"A review of the efficacy of mitomycin C in glaucoma filtration surgery","volume":"9","author":"Al Habash","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1167\/iovs.66.13.48","article-title":"Single-cell transcriptomics shows cellular heterogeneity, intercellular communication, and extracellular matrix remodeling in corneal fibrosis in vivo","volume":"66","author":"Kumar","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"486","DOI":"10.18502\/jovr.v17i4.12300","article-title":"The inhibitory effect of connective tissue growth factor antibody on postoperative fibrosis in a rabbit model of trabeculectomy","volume":"17","author":"Hassanpour","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"key":"bib48","first-page":"2490","article-title":"Fibroblast growth factor reversal of the corneal myofibroblast phenotype","volume":"42","author":"Maltseva","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib49","first-page":"2835","article-title":"Concentration-dependent effects of transforming growth factor \u00df1 on corneal wound healing","volume":"17","author":"Wang","year":"2011","journal-title":"Mol Vis"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1091\/mbc.e06-10-0912","article-title":"Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation","volume":"18","author":"Bernstein","year":"2007","journal-title":"Mol Biol Cell"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1096\/fj.05-4838fje","article-title":"FAK-dependent regulation of myofibroblast differentiation","volume":"20","author":"Greenberg","year":"2006","journal-title":"FASEB J"},{"key":"bib52","doi-asserted-by":"crossref","first-page":"3762674","DOI":"10.1155\/2016\/3762674","article-title":"Comparison of subconjunctival mitomycin C and 5-fluorouracil injection for needle revision of early failed trabeculectomy blebs","volume":"2016","author":"Liu","year":"2016","journal-title":"J Ophthalmol"},{"key":"bib53","article-title":"Steps for saving failing blebs after trabeculectomy","author":"Arosemena","year":"2004","journal-title":"Healio, Ocular Surgery News"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/s41433-018-0199-8","article-title":"Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure","volume":"32","author":"Lin","year":"2018","journal-title":"Eye (Lond)"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/archophthalmol.2009.161","article-title":"Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study","volume":"127","author":"Elner","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/00061198-199300240-00008","article-title":"Histopathology of an avascular filtering bleb after trabeculectomy with mitomycin-C","volume":"2","author":"Mietz","year":"1993","journal-title":"J Glaucoma"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/archopht.1996.01100140151007","article-title":"Endophthalmitis after filtering surgery with mitomycin","volume":"114","author":"Greenfield","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1001\/archopht.120.3.297","article-title":"Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin","volume":"120","author":"DeBry","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/archopht.119.7.1001","article-title":"Risk factors for late-onset infection following glaucoma filtration surgery","volume":"119","author":"Jampel","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"bib60","article-title":"Daam1 negatively regulates USP10 activity","author":"Phillips","year":"2022.","journal-title":"bioRxiv Preprint"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.1093\/nar\/gky745","article-title":"Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs","volume":"46","author":"Shmushkovich","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"e66434","DOI":"10.1371\/journal.pone.0066434","article-title":"BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo","volume":"8","author":"Tandon","year":"2013","journal-title":"PLoS One"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"e0172928","DOI":"10.1371\/journal.pone.0172928","article-title":"Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo","volume":"12","author":"Gupta","year":"2017","journal-title":"PLoS One"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1167\/iovs.17-23308","article-title":"Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo","volume":"59","author":"Gupta","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.exer.2019.107709","article-title":"Corneal injury: clinical and molecular aspects","volume":"186","author":"Barrientez","year":"2019","journal-title":"Exp Eye Res"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13311-019-00736-1","article-title":"Nucleic acid therapeutics for neurological diseases","volume":"16","author":"Watts","year":"2019","journal-title":"Neurotherapeutics"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1124\/molpharm.124.000895","article-title":"The growing class of novel RNAi therapeutics","volume":"106","author":"Traber","year":"2024","journal-title":"Mol Pharmacol"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12561","article-title":"Progress on ocular siRNA gene-silencing therapy and drug delivery systems","volume":"35","author":"Jiang","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/pharmaceutics17101326","article-title":"Targeting the eye: RNA-based therapies, interferences, and delivery strategies","volume":"17","author":"Hassan","year":"2025","journal-title":"Pharmaceutics"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12885-024-12549-3","article-title":"System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening","volume":"24","author":"Zeng","year":"2024","journal-title":"BMC Cancer"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/1873-3468.14763","article-title":"The deubiquitinase USP10 mediates crosstalk between the LKB1\/AMPK axis and Wnt\/\u00df-catenin signaling in cancer","volume":"597","author":"Wang","year":"2023","journal-title":"FEBS Lett"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"990195","DOI":"10.3389\/fonc.2022.990195","article-title":"Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: assessing its role in tumor prognosis and immune response","volume":"12","author":"Ye","year":"2022","journal-title":"Front Oncol"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.stemcr.2014.07.006","article-title":"Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage","volume":"3","author":"Rasmussen","year":"2014","journal-title":"Stem Cell Reports"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3727\/096368910X557173","article-title":"Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-alpha","volume":"20","author":"Chou","year":"2011","journal-title":"Cell Transplant"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"116468","DOI":"10.1016\/j.ejmech.2024.116468","article-title":"Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression","volume":"272","author":"Lu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","article-title":"USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP\/TAZ","volume":"80","author":"Zhu","year":"2020","journal-title":"Cancer Res"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fphar.2017.00223","article-title":"Topical ophthalmic formulation of trichostatin A and SurR9-C84A for quick recovery post-alkali burn of corneal haze","volume":"8","author":"Roy","year":"2017","journal-title":"Front Pharmacol"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/pharmaceutics15082059","article-title":"Sustained inhibition of VEGF and TNF-alpha achieves multi-ocular protection and prevents formation of blood vessels after severe ocular trauma","volume":"15","author":"Zhou","year":"2023","journal-title":"Pharmaceutics"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/wrr.12644","article-title":"Use of an ocular wound chamber for the prevention of exposure keratopathy in a guinea pig model","volume":"26","author":"Holt","year":"2018","journal-title":"Wound Repair Regen"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12974-022-02576-x","article-title":"The cytokine IL-27 reduces inflammation and protects photoreceptors in a mouse model of retinal degeneration","volume":"19","author":"Nortey","year":"2022","journal-title":"J Neuroinflammation"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2567.2010.03379.x","article-title":"Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10","volume":"132","author":"Lee","year":"2011","journal-title":"Immunology"},{"key":"bib86","first-page":"1425","article-title":"Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery","volume":"17","author":"Jiang","year":"2011","journal-title":"Mol Vis"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.4103\/ijo.IJO_1780_18","article-title":"Blockade of IL-27 signaling ameliorates herpes stromal keratitis with upregulated CD4(+) Foxp3(+) regulatory T cells influx in mice","volume":"67","author":"Xia","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.3390\/jcm9113457","article-title":"Cytokines and pathogenesis of central retinal vein occlusion","volume":"9","author":"Noma","year":"2020","journal-title":"J Clin Med"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"4256183","DOI":"10.1155\/2016\/4256183","article-title":"Profiles of inflammatory cytokines in the vitreous fluid from patients with rhegmatogenous retinal detachment and their correlations with clinical features","volume":"2016","author":"Takahashi","year":"2016","journal-title":"Biomed Res Int"},{"key":"bib90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2025.02.002","article-title":"Relationship between chemokine in aqueous humor and primary glaucoma: a meta-analysis","volume":"273","author":"Sun","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"bib91","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/mi.2016.119","article-title":"Lacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation","volume":"10","author":"Ji","year":"2017","journal-title":"Mucosal Immunol"},{"key":"bib92","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"bib93","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12079-018-00500-8","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) in diabetic retinopathy: latest evidence and clinical considerations","volume":"13","author":"Taghavi","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"bib94","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/aos.14537","article-title":"Changes in aqueous and vitreous inflammatory cytokine levels in neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"99","author":"Minaker","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"bib95","first-page":"1493","article-title":"MCP-1 expression in endotoxin-induced uveitis","volume":"43","author":"Tuaillon","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"859951","DOI":"10.3389\/fphar.2022.859951","article-title":"A review of intraocular biomolecules in retinal vein occlusion: toward potential biomarkers for companion diagnostics","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"bib97","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1073\/pnas.95.11.6273","article-title":"Eotaxin is required for the baseline level of tissue eosinophils","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib98","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.4049\/jimmunol.166.12.7571","article-title":"Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells","volume":"166","author":"Salcedo","year":"2001","journal-title":"J Immunol"},{"key":"bib99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"bib100","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2147\/OPTH.S63790","article-title":"Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis","volume":"9","author":"Chigbu","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"bib101","doi-asserted-by":"publisher","first-page":"e0138020","DOI":"10.1371\/journal.pone.0138020","article-title":"Effects of granulocyte-macrophage colony-stimulating (GM-CSF) factor on corneal epithelial cells in corneal wound healing model","volume":"10","author":"Rho","year":"2015","journal-title":"PLoS One"},{"key":"bib102","doi-asserted-by":"publisher","first-page":"109539","DOI":"10.1016\/j.exer.2023.109539","article-title":"Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn","volume":"233","author":"Li","year":"2023","journal-title":"Exp Eye Res"},{"key":"bib103","doi-asserted-by":"crossref","first-page":"2518568","DOI":"10.1155\/2018\/2518568","article-title":"Flt3 regulation in the mononuclear phagocyte system promotes ocular neovascularization","volume":"2018","author":"Gao","year":"2018","journal-title":"J Ophthalmol"},{"key":"bib104","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.omtn.2019.07.018","article-title":"Anti-angiogenic and anti-scarring dual action of an anti-fibroblast growth factor 2 aptamer in animal models of retinal disease","volume":"17","author":"Matsuda","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"bib105","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41433-023-02849-6","article-title":"Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study","volume":"38","author":"Pereira","year":"2024","journal-title":"Eye (Lond)"},{"key":"bib106","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/s41598-022-20036-7","article-title":"FGF-2 enhances fibrogenetic changes in TGF-\u00df2 treated human conjunctival fibroblasts","volume":"12","author":"Tsugeno","year":"2022","journal-title":"Sci Rep"},{"key":"bib107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2018.01.011","article-title":"670 nm light treatment following retinal injury modulates Muller cell gliosis: Evidence from in vivo and in vitro stress models","volume":"169","author":"Lu","year":"2018","journal-title":"Exp Eye Res"},{"key":"bib108","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3390\/ijms26052327","article-title":"Fighting bleb fibrosis after glaucoma surgery: updated focus on key players and novel targets for therapy","volume":"26","author":"Sacchi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"bib109","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12886-021-02090-3","article-title":"Effect of SMILE-derived decellularized lenticules as an adhesion barrier in a rabbit model of glaucoma filtration surgery","volume":"21","author":"Yin","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"bib110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/tvst.11.1.30","article-title":"Effects of valproic acid and mitomycin C combination therapy in a rabbit model of minimally invasive glaucoma surgery","volume":"11","author":"Seet","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"bib111","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/tvst.11.8.29","article-title":"Wound healing response after bleb-forming glaucoma surgery with a SIBS microshunt in rabbits","volume":"11","author":"van Mechelen","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"bib112","doi-asserted-by":"publisher","first-page":"e2300075","DOI":"10.1002\/mabi.202300075","article-title":"A degradable sustained-release drug delivery system for bleb-forming glaucoma surgery","volume":"23","author":"van Mechelen","year":"2023","journal-title":"Macromol Biosci"},{"key":"bib113","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1038\/s41598-024-54960-7","article-title":"In vivo evaluation of a nanotechnology-based microshunt for filtering glaucoma surgery","volume":"14","author":"Gniesmer","year":"2024","journal-title":"Sci Rep"},{"key":"bib114","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/ceo.14578","article-title":"Inhibitory effects of 3',4'-dihydroxyflavonol in a rabbit model of minimally invasive bleb surgery with PreserFlo MicroShunt","volume":"53","author":"Pasvanis","year":"2025","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.12.38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:30:41Z","timestamp":1792589441000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.12.38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.12.38","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}